BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 8738213)

  • 41. Sites of vulnerability on ricin B chain revealed through epitope mapping of toxin-neutralizing monoclonal antibodies.
    Vance DJ; Poon AY; Mantis NJ
    PLoS One; 2020; 15(11):e0236538. PubMed ID: 33166282
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Identification and characterization of a monoclonal antibody recognizing a galactose-binding domain of the toxin ricin.
    Colombatti M; Johnson VG; Skopicki HA; Fendley B; Lewis MS; Youle RJ
    J Immunol; 1987 May; 138(10):3339-44. PubMed ID: 2437188
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Chimeric toxin of the A-subunit of viscumin and the B-subunit of ricin].
    Tonevitskiĭ AG; Toptygin AIu; Agapov II; Shamshiev AT; Pfuller U; Ershova GV; Prokof'ev SA; Rakhmanova VA
    Mol Biol (Mosk); 1994; 28(3):574-9. PubMed ID: 7519722
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Modification of ricin A chain, by addition of endoplasmic reticulum (KDEL) or Golgi (YQRL) retention sequences, enhances its cytotoxicity and translocation.
    Zhan J; Stayton P; Press OW
    Cancer Immunol Immunother; 1998 Mar; 46(1):55-60. PubMed ID: 9520293
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Blockade of the galactose-binding sites of ricin by its linkage to antibody. Specific cytotoxic effects of the conjugates.
    Thorpe PE; Ross WC; Brown AN; Myers CD; Cumber AJ; Foxwell BM; Forrester JT
    Eur J Biochem; 1984 Apr; 140(1):63-71. PubMed ID: 6608447
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Antibody-ricin conjugates: a method of linkage which blocks the galactose binding site of ricin.
    Foxwell BM; Ross WC; Thorpe PE
    Behring Inst Mitt; 1984 May; (74):101-7. PubMed ID: 6477350
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Monovalent and polyvalent carbohydrate inhibitors of ricin binding to a model of the cell-surface receptor.
    Dawson RM; Alderton MR; Wells D; Hartley PG
    J Appl Toxicol; 2006; 26(3):247-52. PubMed ID: 16489581
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Degradation of ricin A chain by endosomal and lysosomal enzymes--the protective role of ricin B chain.
    Bilge A; Howell-Clark J; Ramakrishnan S; Press OW
    Ther Immunol; 1994 Aug; 1(4):197-204. PubMed ID: 7584495
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Assessment of ligand effects in intracellular trafficking of ricin A chain using anti-ricin hybridomas.
    Kornfeld SB; Leonard JE; Mullen MD; Taetle R
    Cancer Res; 1991 Mar; 51(6):1689-93. PubMed ID: 1998959
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mutational and structural analysis of the lectin activity in binding domain 2 of ricin B chain.
    Lehar SM; Pedersen JT; Kamath RS; Swimmer C; Goldmacher VS; Lambert JM; Blättler WA; Guild BC
    Protein Eng; 1994 Oct; 7(10):1261-6. PubMed ID: 7855142
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Modification of the binding site(s) of lectins by an affinity column carrying an activated galactose-terminated ligand.
    Moroney SE; D'Alarcao LJ; Goldmacher VS; Lambert JM; Blättler WA
    Biochemistry; 1987 Dec; 26(25):8390-8. PubMed ID: 3442663
    [TBL] [Abstract][Full Text] [Related]  

  • 52. In vivo depletion of mannose receptor bearing cells from rat liver by ricin A chain: effects on clearance of beta-glucuronidase.
    Simmons BM; Stahl PD; Russell JH
    Biochem Biophys Res Commun; 1987 Jul; 146(2):849-54. PubMed ID: 2441698
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Sugar-complex structures of the C-half domain of the galactose-binding lectin EW29 from the earthworm Lumbricus terrestris.
    Suzuki R; Kuno A; Hasegawa T; Hirabayashi J; Kasai KI; Momma M; Fujimoto Z
    Acta Crystallogr D Biol Crystallogr; 2009 Jan; 65(Pt 1):49-57. PubMed ID: 19153466
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Monoclonal antibody-ricin A chain conjugates (immunotoxins): potential therapeutic agents for human colon carcinoma.
    Gallagher WJ; Burk MW
    J Surg Res; 1986 Feb; 40(2):159-66. PubMed ID: 3945071
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Studies on the galactose-binding site of ricin and the hybrid toxin Man6P-ricin.
    Youle RJ; Murray GJ; Neville DM
    Cell; 1981 Feb; 23(2):551-9. PubMed ID: 7471212
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Expression of rabies glycoprotein and ricin toxin B chain (RGP-RTB) fusion protein in tomato hairy roots: a step towards oral vaccination for rabies.
    Singh A; Srivastava S; Chouksey A; Panwar BS; Verma PC; Roy S; Singh PK; Saxena G; Tuli R
    Mol Biotechnol; 2015 Apr; 57(4):359-70. PubMed ID: 25519901
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Ricin uses arginine 235 as an anchor residue to bind to P-proteins of the ribosomal stalk.
    Zhou Y; Li XP; Chen BY; Tumer NE
    Sci Rep; 2017 Feb; 7():42912. PubMed ID: 28230053
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Galactose-induced dimerization of blocked ricin at acidic pH: evidence for a third galactose-binding site in ricin B-chain.
    Venkatesh YP; Lambert JM
    Glycobiology; 1997 Apr; 7(3):329-35. PubMed ID: 9147041
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Milk inhibits the biological activity of ricin.
    Rasooly R; He X; Friedman M
    J Biol Chem; 2012 Aug; 287(33):27924-9. PubMed ID: 22733821
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Surface plasmon resonance analysis of ricin binding to plasma membranes isolated from NIH 3T3 cells.
    Blome MC; Petro KA; Schengrund CL
    Anal Biochem; 2010 Jan; 396(2):212-6. PubMed ID: 19800858
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.